Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the Lilly Medical website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical

  1. Medical Information Right
  2. Diabetes Right
  3. Rezvoglar (insulin glargine-aglr) injection Right
  4. Is the formulation of Rezvoglar™ (insulin glargine‑aglr) and Basaglar® (insulin glargine) the same?
Search Rezvoglar (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Rezvoglar ™ (insulin glargine-aglr) injection

3 mL (100 units/mL)

Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Is the formulation of Rezvoglar™ (insulin glargine‑aglr) and Basaglar® (insulin glargine) the same?

Rezvoglar and Basaglar are insulin glargine 100 units/mL products that have the same formulation.

US_cFAQ_REZ022_FORMULATION_VS_BASAGLAR
US_cFAQ_REZ022_FORMULATION_VS_BASAGLARen-US

Formulations of Rezvoglar and Basaglar

The inactive ingredients used in the formulation of Rezvoglar™ (insulin glargine‑aglr) 100 units/mL are the same as those in Basaglar® (insulin glargine) 100 units/mL (Excipients Contained in Rezvoglar and Basaglar Prefilled Pens).1,2

Excipients Contained in Rezvoglar and Basaglar Prefilled Pens1-3

Inactive Ingredient

Rezvoglar

Basaglar

Zinca, mcg/mL

30

30

Metacresol, mg/mL

2.7

2.7

Glycerinb, mg/mL

17

17

Hydrochloric acid 10%

For pH adjustmentc

Sodium hydroxide 10%

For pH adjustmentc

Water for Injection, USP

QS to 3 mL

Abbreviations: Basaglar = Basaglar® (insulin glargine) 100 units/mL; QS = quantum sufficit; Rezvoglar = Rezvoglar™ (insulin glargine‑aglr) 100 units/mL; USP = United States Pharmacopeia.

aTo provide zinc ion.

b100% glycerin is used.

cThe pH is approximately 4.

Enclosed Prescribing Information

BASAGLAR® (insulin glargine) injection, for subcutaneous use, Lilly

REZVOGLAR™ (insulin glargine-aglr) injection, for subcutaneous use, Lilly

References

1Rezvoglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2024.

2Basaglar [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.

3Data on file, Eli Lilly and Company and/or one of its subsidiaries.

Date of Last Review: February 11, 2025

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Consumer Health Privacy Notice
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.44 4/2025 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2025. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    California Consumer Privacy Act (CCPA) Opt-Out Icon Your Privacy Choices
    Cookie Settings
    facebook twitter linkedin
    visit www.phactmi.org
    Lilly